Literature DB >> 13109098

Inhibition of Theiler's encephalomyelitis virus (GDVII strain) of mice by an intestinal mucopolysaccharide. II. Purification and properties of the mucopolysaccharide.

B MANDEL, E RACKER.   

Abstract

A mucopolysaccharide inhibitor of Theiler's GDVII virus has been purified from intestinal tissue of adult mice. The purified material has been shown to consist chiefly of carbohydrate. Following acid hydrolysis of the inhibitor, several amino adds were found to be present. The carbohydrate components shown to be present thus far are galactose, hexosamine, N-acetylhexosamine, methylpentose, hexurornic acid; an indication has been obtained that sedoheptulose is also present. The available evidence strongly suggests that this mucopolysaccharide, and not some other substance present in minute amounts, is the inhibitor of the GDVII virus.

Entities:  

Keywords:  ENCEPHALOMYELITIS/experimental; POLYSACCHARIDES; VIRUSES

Mesh:

Substances:

Year:  1953        PMID: 13109098      PMCID: PMC2136332          DOI: 10.1084/jem.98.5.417

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Qualitative analysis of proteins: a partition chromatographic method using paper.

Authors:  R Consden; A H Gordon; A J Martin
Journal:  Biochem J       Date:  1944       Impact factor: 3.857

2.  Studies in immunochemistry: 7. The isolation from hog gastric mucin of the polysaccharide-amino acid complex possessing blood group A specificity.

Authors:  W T Morgan; H K King
Journal:  Biochem J       Date:  1943       Impact factor: 3.857

3.  A colorimetric method for the determination of N-acetylglucosamine and N-acetylchrondrosamine.

Authors:  W T Morgan; L A Elson
Journal:  Biochem J       Date:  1934       Impact factor: 3.857

4.  New specific color reactions of hexoses and spectrophotometric micromethods for their determination.

Authors:  Z DISCHE; L B SHETTLES; M OSNOS
Journal:  Arch Biochem       Date:  1949-06

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Studies in immunochemistry. X. The isolation and properties of Lewis (Lea) human blood group substance.

Authors:  E F ANNISON; W T J MORGAN
Journal:  Biochem J       Date:  1952-02       Impact factor: 3.857

7.  The chemical and antiviral properties of the somatic antigen of Phase II Shigella sonnei.

Authors:  M A JESAITIS; W F GOEBEL
Journal:  J Exp Med       Date:  1952-11       Impact factor: 14.307

8.  A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses.

Authors:  I TAMM; F L HORSFALL
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307

9.  The nature of the virus receptors of red cells; evidence on the chemical nature of the virus receptors of red cells and of the existence of a closely analogous substance in normal serum.

Authors:  G K HIRST
Journal:  J Exp Med       Date:  1948-04-01       Impact factor: 14.307

10.  Inhibition of Theiler's encephalomyelitis virus (GDVII strain) of mice by an intestinal mucopolysaccharide. I. Biological properties and mechanism of action.

Authors:  B MANDEL; E RACKER
Journal:  J Exp Med       Date:  1953-11       Impact factor: 14.307

View more
  4 in total

1.  [Fucose containing mucins predominantly of entodermal origin with blood group and other biological characteristics].

Authors:  G F SPRINGER
Journal:  Klin Wochenschr       Date:  1955-04-15

2.  Serum and tissue inhibitors of virus.

Authors:  H S GINSBERG
Journal:  Bacteriol Rev       Date:  1960-03

3.  [Studies on the content of fucose in serum and protein fractions. I. Method of determination and normal value in serum].

Authors:  M JACUBEIT; P BRUNGER; M KNEDEL
Journal:  Klin Wochenschr       Date:  1959-04-15

4.  Inhibition of Theiler's encephalomyelitis virus (GDVII strain) of mice by an intestinal mucopolysaccharide. I. Biological properties and mechanism of action.

Authors:  B MANDEL; E RACKER
Journal:  J Exp Med       Date:  1953-11       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.